In ovarian cancer, MEG3 overexpression has been repeatedly shown to decrease migration and invasion, further supporting our finding that MEG3 deficiency permits higher expression of MMPs and greater invasive activity (Sun et al., 2016). This evidence concerns the gene MEG3 and ovarian carcinoma.